Inventor · disambiguated record
Sean M. Sullivan
Also filed as: SULLIVAN SEAN · SULLIVAN SEAN M · SULLIVAN SEAN MICHAEL
19 granted patents·15 pending applications·847 citations·filing 1990–2024
95Inventor score
Files withARCTURUS THERAPEUTICS INC7RIBOZYME PHARM INC7HARTIKKA JUKKA2RODOS BIOTARGET GMBH2VESTAR INC2
Top patents by PatentIndex Score
34 records- 0197US5227170AEncapsulation processVESTAR INC·Filed 1990·Granted Jul 13, 1993·329 cites·14 claims
- 0295US11744887B2Coronavirus vaccine compositions and methodsARCTURUS THERAPEUTICS INC·Filed 2021·Granted Sep 5, 2023·4 cites·28 claims
- 0394US12220455B2Coronavirus vaccine compositions and methodsARCTURUS THERAPEUTICS INC·Filed 2023·Granted Feb 11, 2025·1 cites·33 claims
- 0492US5583020APermeability enhancers for negatively charged polynucleotidesRIBOZYME PHARM INC·Filed 1993·Granted Dec 10, 1996·318 cites·30 claims
- 0589US2025161434A1Coronavirus vaccine compositions and methodsARCTURUS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0688US12390524B2Compositions and methods for inducing immune responsesARCTURUS THERAPEUTICS INC·Filed 2023·Granted Aug 19, 2025·0 cites·22 claims
- 0788US11759515B2Compositions and methods for inducing immune responsesARCTURUS THERAPEUTICS INC·Filed 2021·Granted Sep 19, 2023·1 cites·27 claims
- 0888US9102950B2Compositions and methods for enhancing immune responses to vaccinesVICAL INC·Filed 2013·Granted Aug 11, 2015·9 cites·11 claims
- 0987US5811300ATNF-α ribozymesRIBOZYME PHARM INC·Filed 1994·Granted Sep 22, 1998·95 cites·13 claims
- 1078US7339042B2Gene delivery to tumorsUNIV FLORIDA·Filed 2004·Granted Mar 4, 2008·4 cites·4 claims
- 1175US5616490ARibozymes targeted to TNF-α RNARIBOZYME PHARM INC·Filed 1995·Granted Apr 1, 1997·32 cites·8 claims
- 1274US6436644B1Ribozyme treatment of diseases or conditions related to levels of intercellular adhesion molecule-1 (CAM-1)RIBOZYME PHARM INC·Filed 2000·Granted Aug 20, 2002·2 cites·19 claims
- 1369US2024301007A1Methods and compositions for quadrivalent influenza vaccineARCTURUS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1468US5837542AIntercellular adhesion molecule-1 (ICAM-1) ribozymesRIBOZYME PHARM INC·Filed 1994·Granted Nov 17, 1998·20 cites·13 claims
- 1566US5616488AIL-5 targeted ribozymesRIBOZYME PHARM INC·Filed 1994·Granted Apr 1, 1997·23 cites·22 claims
- 1661US2009191227A1Compositions and Methods for Enhancing Immune Responses to VaccinesVICAL INC·Filed 2008·Application pending·0 cites
- 1759US2023219996A1Rna vaccinesARCTURUS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1856US8999345B2Compositions and methods for enhancing immune responses to vaccinesHARTIKKA JUKKA·Filed 2012·Granted Apr 7, 2015·0 cites·1 claims
- 1950US2023043046A1Recombinant CDKL5 Proteins, Gene Therapy and Production MethodsAMICUS THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2048US11586753B2Secure content access systemBEATPORT LLC·Filed 2020·Granted Feb 21, 2023·0 cites·9 claims
- 2148US2005142114A1Targeted lipid-drug formulations for delivery of drugs to myeloid and lymphoid immune cellsFiled 2004·Application pending·0 cites
- 2248US2001044147A1Delivery vehicles comprising stable lipid/nucleic acid complexesFiled 2001·Application pending·0 cites
- 2347US2012014976A1Compositions and methods for enhancing immune responses to vaccinesHARTIKKA JUKKA·Filed 2011·Application pending·0 cites
- 2447US2002022264A1Delivery vehicles comprising stable lipid/nucleic acid complexesFiled 2001·Application pending·0 cites
- 2545US2008207544A1Compositions And Methods For Delivery Of Agents Into CellsSULLIVAN SEAN M·Filed 2006·Application pending·0 cites
- 2644US2003198664A1Lipid mediated screening of drug candidates for identification of active compoundsFiled 2003·Application pending·0 cites
- 2741US2002082237A1Cationic polymers and lipids for the delivery of nucleic acidsFiled 2002·Application pending·0 cites
- 2840US6132967ARibozyme treatment of diseases or conditions related to levels of intercellular adhesion molecule-1 (ICAM-1)RIBOZYME PHARM INC·Filed 1998·Granted Oct 17, 2000·2 cites·24 claims
- 2940US5419914APhospholipid analogue vesicleVESTAR INC·Filed 1994·Granted May 30, 1995·7 cites·16 claims
- 3040US2014234400A1Targeted Lipid-Drug Formulations for Delivery of Drugs to Myeloid and Lymphoid Immune CellsRODOS BIO TARGET GMBH·Filed 2014·Application pending·0 cites
- 3138US10719616B2Secure content access systemPULSELOCKER INC·Filed 2017·Granted Jul 21, 2020·0 cites·20 claims
- 3237US10357457B2Targeted lipid-drug formulations for delivery of drugs to myeloid and lymphoid immune cellsRODOS BIOTARGET GMBH·Filed 2016·Granted Jul 23, 2019·0 cites·8 claims
- 3328US2001007771A1Cationic polymers and lipids for the delivery of nucleic acidsFiled 1997·Application pending·0 cites
- 3421US2018235992A1Immunotherapies for malignant, neurodegenerative and demyelinating diseases by the use of targeted nanocarriersRODOS BIOTARGET GMBH·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sean M. Sullivan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →